| B‐cell receptor signalling and its crosstalk with other pathways in normal and malignant cells V Seda, M Mraz European journal of haematology 94 (3), 193-205, 2015 | 309 | 2015 |
| The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy G Pavlasova, M Mraz Haematologica 105 (6), 1494, 2020 | 280 | 2020 |
| MicroRNA isolation and stability in stored RNA samples M Mráz, K Malinova, J Mayer, S Pospisilova Biochemical and biophysical research communications 390 (1), 1-4, 2009 | 279 | 2009 |
| MicroRNAs in B-cell lymphomas: how a complex biology gets more complex K Musilová, M Mráz Leukemia 29 (5), 1004-1017, 2015 | 274 | 2015 |
| MicroRNA biogenesis, functionality and cancer relevance B Kusenda, M Mraz, J Mayer, S Pospisilova Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150 (2), 205-215, 2006 | 254 | 2006 |
| MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia B Cui, L Chen, S Zhang, M Mraz, JF Fecteau, J Yu, EM Ghia, L Zhang, ... Blood, The Journal of the American Society of Hematology 124 (4), 546-554, 2014 | 243 | 2014 |
| miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities M Mráz, K Malinova, J Kotaskova, S Pavlova, B Tichy, J Malcikova, ... Leukemia 23 (6), 1159-1163, 2009 | 240 | 2009 |
| Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia J Malcikova, K Stano-Kozubik, B Tichy, B Kantorová, S Pavlova, N Tom, ... Leukemia 29 (4), 877-885, 2015 | 192 | 2015 |
| MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia K Vargova, N Curik, P Burda, P Basova, V Kulvait, V Pospisil, F Savvulidi, ... Blood, The Journal of the American Society of Hematology 117 (14), 3816-3825, 2011 | 180 | 2011 |
| miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1 M Mraz, L Chen, LZ Rassenti, EM Ghia, H Li, K Jepsen, EN Smith, ... Blood, The Journal of the American Society of Hematology 124 (1), 84-95, 2014 | 176 | 2014 |
| MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes M Mraz, M Mraz, S Pospisilova, K Malinova, I Slapak, J Mayer Leukemia & lymphoma 50 (3), 506-509, 2009 | 170 | 2009 |
| Bone marrow stromal cells protect lymphoma B‐cells from rituximab‐induced apoptosis and targeting integrin α‐4‐β‐1 (VLA‐4) with natalizumab can overcome this resistance M Mraz, CS Zent, AK Church, DF Jelinek, X Wu, S Pospisilova, SM Ansell, ... British journal of haematology 155 (1), 53-64, 2011 | 154 | 2011 |
| MicroRNAs Regulate p21Waf1/Cip1 Protein Expression and the DNA Damage Response in Human Embryonic Stem Cells D Dolezalova, M Mraz, T Barta, K Plevova, V Vinarsky, Z Holubcova, ... Stem cells 30 (7), 1362-1372, 2012 | 145 | 2012 |
| Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis G Pavlasova, M Borsky, V Seda, K Cerna, J Osickova, M Doubek, J Mayer, ... Blood, The Journal of the American Society of Hematology 128 (12), 1609-1613, 2016 | 131 | 2016 |
| MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia M Mraz, D Dolezalova, K Plevova, K Stano Kozubik, V Mayerova, K Cerna, ... Blood, The Journal of the American Society of Hematology 119 (9), 2110-2113, 2012 | 116 | 2012 |
| Missense mutations located in structural p53 DNA-binding motifs are associated with extremely poor survival in chronic lymphocytic leukemia M Trbusek, J Smardova, J Malcikova, L Sebejova, P Dobes, M Svitakova, ... Journal of clinical oncology 29 (19), 2703-2708, 2011 | 116 | 2011 |
| MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back M Mraz, S Pospisilova Expert review of hematology 5 (6), 579-581, 2012 | 94 | 2012 |
| MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia M Mraz, TJ Kipps Leukemia & lymphoma 54 (8), 1836-1839, 2013 | 77 | 2013 |
| Genetic and non-genetic mechanisms of resistance to BCR signaling inhibitors in B cell malignancies L Ondrisova, M Mraz Frontiers in oncology 10, 591577, 2020 | 63 | 2020 |
| Micro RNA and mesial temporal lobe epilepsy with hippocampal sclerosis: whole mi RN ome profiling of human hippocampus P Bencurova, J Baloun, K Musilova, L Radova, B Tichy, M Pail, M Zeman, ... Epilepsia 58 (10), 1782-1793, 2017 | 58 | 2017 |
Mgr. Dasa Bohaciakova (Dolezalova),...Assistant Professor at Masaryk University Brno, Czech Republic在 med.muni.cz 的电子邮件经过验证
